News & Press
Lecanemab
UCSF Memory and Aging Center
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
U.S. Food and Drug Administration
2022 Norman Geschwind Prize recipient Dr. Julio Rojas
UCSF Department of Neurology
Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease
Centers for Medicare & Medicaid Services
The hunt for a simple blood test to detect Alzheimer’s disease
The Mercury News
Interview with Dr VandeVrede, cognitive neurologist at the University of California San Francisco
Fédération des Centres Mémoire
An Introduction to Amyloid-Related Imaging Abnormalities (ARIA) and Its Management - CME
Alzheimer's Association
Resources for Aducanumab
UCSF Memory and Aging Center
FTD Trials: The Now and the Future
ALZFORUM